Milestone Pharmaceuticals (MIST) Capital Expenditures (2018 - 2026)
Milestone Pharmaceuticals (MIST) reported Capital Expenditures of $26,000 for Q2 2026, up 136.4% from $11,000 a year earlier but down 42.2% from the prior quarter.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Capital Expenditures (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Milestone Pharmaceuticals' Capital Expenditures came in at $356,000, up 727.9% year-over-year; for FY2025, it was $302,000, up 815.2% from FY2024.
- Capital Expenditures has a three-year compound annual growth rate of 3.5% (FY2022 to FY2025).
- By year, Capital Expenditures came in at $33,000 in FY2024 (-70.5%), $112,000 in FY2023 (-58.8%) and $272,000 in FY2022.
- Five-year quarterly Capital Expenditures spans a low of $2,000 in Q3 2025 and a high of $283,000 in Q4 2025.
- Year over year, Capital Expenditures gained in two of the last five quarters, with growth averaging 125.9%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $45,000 (Q1 2026), $283,000 (Q4 2025) and $2,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Milestone Pharmaceuticals | 82.17 Mn | -88.43 Mn | 527,000.00 | 26,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26,000.00 |
| Mar 31, 2026 | 45,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 110,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Dec 31, 2019 | 101,000.00 |
| Sep 30, 2019 | 294,000.00 |
| Mar 31, 2018 | 5,000.00 |
API Access
Milestone Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();